These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4231355)

  • 21. [Mechanism of the development of tuberculin allergy and its relationship to acquired immunity in respect to constituents of tubercle bacillus].
    Takahashi Y
    Jpn J Tuberc; 1967 Dec; 14(3):67-95. PubMed ID: 4970909
    [No Abstract]   [Full Text] [Related]  

  • 22. [Comparison of protective effect of killed and live BCG bacilli and INH-resistant tubercle bacilli in guinea pigs].
    Paklerska-Pobratyn H; Kostrzeński W
    Gruzlica; 1968 Jun; 36(6):509-16. PubMed ID: 4970098
    [No Abstract]   [Full Text] [Related]  

  • 23. The isolation from romanian BCG substrain of non cross reacting antigens to Mycobacterium tuberculosis H37Rv strain.
    Niculescu D; Stavri D; Stavri H; Claiciu I; Bărbulescu R
    Arch Roum Pathol Exp Microbiol; 1983; 42(2-3):213-9. PubMed ID: 6424629
    [No Abstract]   [Full Text] [Related]  

  • 24. Mycobacterium bovis BCG vaccination modulates TNF-alpha production after pulmonary challenge with virulent Mycobacterium tuberculosis in guinea pigs.
    Yamamoto T; Lasco TM; Uchida K; Goto Y; Jeevan A; McFarland C; Ly L; Yamamoto S; McMurray DN
    Tuberculosis (Edinb); 2007 Mar; 87(2):155-65. PubMed ID: 17289434
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Progressive pulmonary tuberculosis is not due to increasing numbers of viable bacilli in rabbits, mice and guinea pigs, but is due to a continuous host response to mycobacterial products.
    Dannenberg AM; Collins FM
    Tuberculosis (Edinb); 2001; 81(3):229-42. PubMed ID: 11466035
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The feasibility of using the fluorescent antibody technic in immunologic studies of tuberculosis].
    Gogebashvili NV; Averbakh MM
    Biull Eksp Biol Med; 1967 Sep; 64(9):71-4. PubMed ID: 4988303
    [No Abstract]   [Full Text] [Related]  

  • 27. Protection against tuberculosis induced by oral prime with Mycobacterium bovis BCG and intranasal subunit boost based on the vaccine candidate Ag85B-ESAT-6 does not correlate with circulating IFN-gamma producing T-cells.
    Badell E; Nicolle F; Clark S; Majlessi L; Boudou F; Martino A; Castello-Branco L; Leclerc C; Lewis DJ; Marsh PD; Gicquel B; Winter N
    Vaccine; 2009 Jan; 27(1):28-37. PubMed ID: 18977269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Chemical and immunological studies on mycobacterial polysaccharides].
    Azuma I
    Kekkaku; 1968 Aug; 43(8):325-7. PubMed ID: 4974527
    [No Abstract]   [Full Text] [Related]  

  • 29. Further purification of polysaccharides having anaphylactic activity from culture filtrate of human tubercle bacilli.
    Azuma I; Kimura H; Yamamura Y
    Am Rev Respir Dis; 1967 Sep; 96(3):536-8. PubMed ID: 4962679
    [No Abstract]   [Full Text] [Related]  

  • 30. [Serologic activity of purified phospholipids of Mycobacterium tuberculosis].
    Sasaki A; Takahashi Y
    C R Seances Soc Biol Fil; 1974; 168(4-5):626-9. PubMed ID: 4281705
    [No Abstract]   [Full Text] [Related]  

  • 31. [Transplacental transport of mycobacterial antibodies in man and animals].
    Okumura T
    Arerugi; 1971 Oct; 20(10):809-16. PubMed ID: 5004302
    [No Abstract]   [Full Text] [Related]  

  • 32. [Biochemical and immunological reactivity of the histoid macrophage in tuberculosis. IV. The effect of hyperimmune serum on the interaction between the tubercular bacillus and the histoid macrophage of the noraml animal and BCG vaccinated animal].
    Păunescu E
    Microbiol Parazitol Epidemiol (Bucur); 1968; 13(1):39-45. PubMed ID: 4970194
    [No Abstract]   [Full Text] [Related]  

  • 33. Development of a Mycobacterium bovis intranasal challenge model in mice.
    Logan KE; Gavier-Widen D; Hewinson RG; Hogarth PJ
    Tuberculosis (Edinb); 2008 Sep; 88(5):437-43. PubMed ID: 18590980
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vaccine-induced cytokine responses in a guinea pig model of pulmonary tuberculosis.
    McMurray DN; Allen SS; Jeevan A; Lasco T; Cho H; Skwor T; Yamamoto T; McFarland C; Yoshimura T
    Tuberculosis (Edinb); 2005; 85(5-6):295-301. PubMed ID: 16253558
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Novel vaccines against M. tuberculosis].
    Okada M
    Kekkaku; 2006 Dec; 81(12):745-51. PubMed ID: 17240920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Phagocytosis of tubercle bacilli by pulmonary macrophages in guinea pigs immunized with BCG].
    Murczyńska W; Przeworska D; Dworak W
    Gruzlica; 1967; 35(11):1151-7. PubMed ID: 4964976
    [No Abstract]   [Full Text] [Related]  

  • 37. Mycobacterium tuberculosis tuberculin devoid of BCG common antigens.
    Stavri D; Stavri H; Claiciu I; Niculescu D
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Mar; 251(3):399-401. PubMed ID: 6805158
    [No Abstract]   [Full Text] [Related]  

  • 38. Mycobacterial antibodies after tuberculin testing, BCG- vaccination, BCG-immunotherapy and against cross-reacting antigens in a solid-phase radioimmunoassay.
    Mauch H; Brehmer W
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Mar; 251(3):380-8. PubMed ID: 6805156
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of chemical and biological properties of water-soluble adjuvants prepared from Mycobacterium tuberculosis, Mycobacterium bovis and Mycobacterium smegmatis.
    Kumazawa Y; Shibusawa A; Nakagawa N; Kojima Y; Mizunoe K
    Kitasato Arch Exp Med; 1976 Dec; 49(4):153-62. PubMed ID: 829910
    [No Abstract]   [Full Text] [Related]  

  • 40. Cross reactivity of Mycobacterium laprae and BCG. A report on further studies.
    Goihman-Yahr M; Convit J
    Int J Lepr Other Mycobact Dis; 1972; 40(1):62-7. PubMed ID: 4562385
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.